Picture of GridAI Technologies logo

GRDX — GridAI Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapMomentum Trap

Brief: First Wave Biopharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial In Cystic Fibrosis

May 11 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA COMPLETES PATIENT SCREENING FOR PHASE
2
SPAN ADRULIPASE CLINICAL TRIAL IN CYSTIC FIBROSIS

Source text for Eikon:  ID:nGNX3Y2GXr 
Further company coverage:  FWBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on GridAI Technologies

See all news